Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06202898 · ClinicalTrials.gov registry record · NA
Economic Navigation and Strengthening to Research Unrestricted Services for Transgender Women (ENTRUST)
A NA study of HIV and AIDS, sponsored by University of Central Florida.
- Recruiting
- Registry status
- NA
- Development phase
- 110
- Enrollment target
- 1
- Study location
NCT06202898: Recruiting NA study of HIV and AIDS, sponsored by University of Central Florida.
NCT06202898 is a NA study of HIV and AIDS that is actively recruiting participants, run by University of Central Florida. The registered enrollment target is 110 participants, below the 440-participant average among 303 other HIV trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06202898, a NA study of HIV and AIDS, is actively recruiting participants, sponsored by University of Central Florida.
- RECRUITING
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall hypothesis is that stabilizing transgender women financially while providing them tailored counselling will increase their odds of them linking to substance use services, PrEP services if they do not have HIV, and transgender women who are living with HIV will be more adherent to their ART treatment.
Primary Outcome
The rate of change of substance abuse incidence for both arms
Conditions Studied
Interventions
- OTHER Control
- OTHER Baseline
- OTHER ENTRUST
Study Locations (1)
Florida
- University of Central Florida - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2023-07-11 |
| Est. Completion | 2027-06 |
| Phase | NA |
What NCT06202898 shows while recruiting
NCT06202898 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 440-participant average among 303 other HIV trials with a reported enrollment target (75% lower).
The record links to 3 conditions, with HIV appearing as the primary indexed condition, and to 3 interventions - of which Control is the first listed.
NCT06202898 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06202898 about?
NCT06202898 is a clinical study titled "Economic Navigation and Strengthening to Research Unrestricted Services for Transgender Women (ENTRUST)". The overall hypothesis is that stabilizing transgender women financially while providing them tailored counselling will increase their odds of them linking to substance use services, PrEP services if they do not have HIV, and transgender women who are living with HIV will be more adherent to their A...
What is the current status of trial NCT06202898?
This trial is currently recruiting. It is a NA study. The enrollment target is 110 participants. The study started on 2023-07-11. Estimated completion is 2027-06.
What conditions does trial NCT06202898 study?
This clinical trial studies the following conditions: HIV, AIDS, Transgender Women.
What interventions are being tested in trial NCT06202898?
The interventions under investigation include: Control (OTHER), Baseline (OTHER), ENTRUST (OTHER).
Who is sponsoring clinical trial NCT06202898?
This trial is sponsored by University of Central Florida, which has 91 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06202898 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06202898's enrollment target sits among peer trials
110 146th of 303 higher than 158 of 303 other HIV trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
-
Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Assessing Peer Support for Physical Activity in Women With HIV and Hypertension
RECRUITING · NA
-
Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI